Gaedigk A - Search Results

1

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.

Goetz MP, Sangkuhl K, Guchelaar HJ, Schwab M, Province M, Whirl-Carrillo M, Symmans WF, McLeod HL, Ratain MJ, Zembutsu H, Gaedigk A, van Schaik RH, Ingle JN, Caudle KE, Klein TE. Goetz MP, et al. Among authors: gaedigk a. Clin Pharmacol Ther. 2018 May;103(5):770-777. doi: 10.1002/cpt.1007. Epub 2018 Jan 31. Clin Pharmacol Ther. 2018. PMID: 29385237 Free PMC article.

2

Interethnic differences of drug-metabolizing enzymes.

Gaedigk A. Gaedigk A. Int J Clin Pharmacol Ther. 2000 Feb;38(2):61-8. doi: 10.5414/cpp38061. Int J Clin Pharmacol Ther. 2000. PMID: 10706192 Review.

3

Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation.

Abdel-Rahman SM, Leeder JS, Wilson JT, Gaedigk A, Gotschall RR, Medve R, Liao S, Spielberg SP, Kearns GL. Abdel-Rahman SM, et al. Among authors: gaedigk a. J Clin Pharmacol. 2002 Jan;42(1):24-9. doi: 10.1177/0091270002042001002. J Clin Pharmacol. 2002. PMID: 11808821

4

Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.

Gaedigk A, Bradford LD, Marcucci KA, Leeder JS. Gaedigk A, et al. Clin Pharmacol Ther. 2002 Jul;72(1):76-89. doi: 10.1067/mcp.2002.125783. Clin Pharmacol Ther. 2002. PMID: 12152006 Clinical Trial.

5

Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis.

Kennedy MJ, Scripture CD, Kashuba AD, Scott CS, Gaedigk A, Kearns GL. Kennedy MJ, et al. Among authors: gaedigk a. Clin Pharmacol Ther. 2004 Mar;75(3):163-71. doi: 10.1016/j.clpt.2003.10.005. Clin Pharmacol Ther. 2004. PMID: 15001967

6

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.

Zineh I, Beitelshees AL, Gaedigk A, Walker JR, Pauly DF, Eberst K, Leeder JS, Phillips MS, Gelfand CA, Johnson JA. Zineh I, et al. Among authors: gaedigk a. Clin Pharmacol Ther. 2004 Dec;76(6):536-44. doi: 10.1016/j.clpt.2004.08.020. Clin Pharmacol Ther. 2004. PMID: 15592325

7

Identification of CYP2D6 impaired functional alleles in Mexican Americans.

Luo HR, Gaedigk A, Aloumanis V, Wan YJ. Luo HR, et al. Among authors: gaedigk a. Eur J Clin Pharmacol. 2005 Dec;61(11):797-802. doi: 10.1007/s00228-005-0044-4. Epub 2005 Nov 8. Eur J Clin Pharmacol. 2005. PMID: 16283274

8

Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events.

Gaedigk A, Ndjountché L, Divakaran K, Dianne Bradford L, Zineh I, Oberlander TF, Brousseau DC, McCarver DG, Johnson JA, Alander SW, Wayne Riggs K, Steven Leeder J. Gaedigk A, et al. Clin Pharmacol Ther. 2007 Feb;81(2):242-51. doi: 10.1038/sj.clpt.6100033. Clin Pharmacol Ther. 2007. PMID: 17259947

9

Ontogeny of dextromethorphan O- and N-demethylation in the first year of life.

Blake MJ, Gaedigk A, Pearce RE, Bomgaars LR, Christensen ML, Stowe C, James LP, Wilson JT, Kearns GL, Leeder JS. Blake MJ, et al. Among authors: gaedigk a. Clin Pharmacol Ther. 2007 Apr;81(4):510-6. doi: 10.1038/sj.clpt.6100101. Epub 2007 Feb 14. Clin Pharmacol Ther. 2007. PMID: 17301735

10

Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype.

Gaedigk A, Eklund JD, Pearce RE, Leeder JS, Alander SW, Phillips MS, Bradford LD, Kennedy MJ. Gaedigk A, et al. Clin Pharmacol Ther. 2007 Jun;81(6):817-20. doi: 10.1038/sj.clpt.6100125. Epub 2007 Mar 28. Clin Pharmacol Ther. 2007. PMID: 17392730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page